| Nivolumab Plus Rituximab in First-line Follicular Lymphoma gr 1-3A (NCT03245021) | Dr. Eliza Hawkes | 2017-09-07 |
| Early Predictors of Necrotizing Enterocolitis in Neonates (NCT03210831) | Nationwide Children's Hospital | 2017-09-06 |
| A Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Participants With Advanced Stage Newly Diagnosed Hodgkin Lymphoma (NCT02979522) | Takeda | 2017-09-06 |
| RESCEU: Defining the Burden of RSV Disease (NCT03698084) | University of Oxford | 2017-09-05 |
| Ipilimumab and Decitabine in Treating Patients With Relapsed or Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia (NCT02890329) | National Cancer Institute (NCI) | 2017-09-05 |
| PRecISion Medicine for Children With Cancer (NCT03336931) | Sydney Children's Hospitals Network | 2017-09-05 |
| A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance (NCT03114865) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-09-05 |
| Palbociclib After CDK and Endocrine Therapy (PACE) (NCT03147287) | Dana-Farber Cancer Institute | 2017-09-05 |
| Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors (NCT03170960) | Exelixis | 2017-09-05 |
| Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients (NCT03212742) | Centre Francois Baclesse | 2017-09-04 |
| Vitamin D and Immune Mechanisms of Hypertension in Type 2 Diabetics (NCT03348280) | Washington University School of Medicine | 2017-09-01 |
| Re-Orchestration of Interregional Oscillatory Activity to Promote Visual Recovery (NCT05220449) | Ecole Polytechnique Fédérale de Lausanne | 2017-09-01 |
| CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells With or Without NKTR-255 in Adults With Recurrent or Refractory B Cell Malignancies (NCT03233854) | Stanford University | 2017-09-01 |
| Effects of Blueberry on Gut Microbiota and Metabolic Syndrome (NCT03266055) | Laval University | 2017-09-01 |
| Lunatocapitate Fusion Versus Four-corner Fusion for SNAC and SLAC Arthritis. (NCT03315377) | Karolinska Institutet | 2017-09-01 |
| From PSA to Stockholm3: Study Part 1 (NCT03381105) | Helse Stavanger HF | 2017-09-01 |
| Sequencing of Radium-223 and Docetaxel in Symptomatic Bone-only Metastatic Castration-resistant Prostate Cancer (NCT03230734) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2017-09-01 |
| Prevention of Incisional Hernia With an Onlay Mesh Visible on MRI (NCT03105895) | Henares University Hospital | 2017-09-01 |
| Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers (NCT03260023) | Transgene | 2017-09-01 |
| Statin Therapy in Patients With Early Stage ADPKD (NCT03273413) | University of Colorado, Denver | 2017-08-31 |
| Tissue Engineering Approaches to Treat COPD (NCT04878445) | University Hospitals of North Midlands NHS Trust | 2017-08-31 |
| Postoperative Hypofractionated Intensity-modulated Radiation Therapy in Cervical Cancer (NCT03239626) | Samsung Medical Center | 2017-08-31 |
| Coronary Microvascular Function and CT Coronary Angiography (CorCTCA) (NCT03477890) | NHS National Waiting Times Centre Board | 2017-08-31 |
| Implementation of Neuro Lung Protective Ventilation (NCT03243539) | Colin Grissom | 2017-08-31 |
| Effect of Tranexamic Acid (TXA) on Reduction of Postoperative Blood Transfusion (NCT03063892) | Gregory M Georgiadis MD | 2017-08-30 |
| WF and PR OCTA in Diabetic Retinopathy (NCT03922932) | Oregon Health and Science University | 2017-08-30 |
| BioVentrix Revivent TC™ System Clinical Study (NCT02931240) | BioVentrix | 2017-08-29 |
| Comprehensive Genomic Profiling of Colorectal Cancer Patients With Isolated Liver Metastases to Understand Response & Resistance to Cancer Therapy (NCT03364621) | University Health Network, Toronto | 2017-08-29 |
| Focal Salvage HDR Brachytherapy for Locally Recurrent Prostate Cancer in Patients Treated With Prior Radiotherapy (NCT03312972) | Loyola University | 2017-08-28 |
| Sapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 Mutations (NCT03047213) | National Cancer Institute (NCI) | 2017-08-24 |
| Paediatric Hepatic International Tumour Trial (NCT03017326) | University of Birmingham | 2017-08-24 |
| Study to Allow Patients Previously Participating in a Novartis Sponsored Trial to Continue Receiving Capmatinib Treatment as Single Agent or in Combination With Other Treatments or the Combination Treatment Alone (NCT03040973) | Novartis Pharmaceuticals | 2017-08-23 |
| Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial) (NCT03213704) | National Cancer Institute (NCI) | 2017-08-23 |
| A Trial of Androgen Deprivation, Docetaxel, and Enzalutamide for Metastatic Prostate Cancer (NCT03246347) | Wake Forest University Health Sciences | 2017-08-23 |
| Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment (NCT02962414) | Novartis Pharmaceuticals | 2017-08-23 |
| ALTERRA: SAPIEN 3 THV With the Alterra Adaptive Prestent (NCT03130777) | Edwards Lifesciences | 2017-08-22 |
| Testing LOXO-101 as Potentially Targeted Treatment in Cancers With NTRK Genetic Changes (MATCH - Subprotocol Z1E) (NCT06390852) | National Cancer Institute (NCI) | 2017-08-21 |
| EXamining PErsonalised Radiation Therapy for Low-risk Early Breast Cancer (NCT02889874) | Breast Cancer Trials, Australia and New Zealand | 2017-08-21 |
| Personalized Therapy Study - Attain Stability Quad Post-Approval Study (NCT04024943) | Medtronic | 2017-08-21 |
| Incidence of Acute Laryngeal Injury Following Endotracheal Intubation (NCT03250975) | Vanderbilt University Medical Center | 2017-08-19 |
| A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma (NCT03008408) | M.D. Anderson Cancer Center | 2017-08-18 |
| Study of E7389 Liposomal Formulation in Participants With Solid Tumor (NCT03207672) | Eisai Co., Ltd. | 2017-08-18 |
| Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy For Locally Advanced Breast Cancer (NCT03255577) | Memorial Sloan Kettering Cancer Center | 2017-08-17 |
| Acoustic Stimulation for Seizure Suppression (NCT03198494) | NYU Langone Health | 2017-08-17 |
| Medial Unicondylar Knee Arthroplasty vs Total Knee Arthroplasty (NCT03396640) | University Hospital, Gentofte, Copenhagen | 2017-08-17 |
| Feasibility and Safety of IMP321 (Eftilagimod Alpha) for Advanced Stage Solid Tumors (NCT03252938) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2017-08-15 |
| Evaluation iNduction, Consolidation and Maintenance Treatment With Isatuximab , Carfilzomib, LEnalidomide and Dexamethasone (NCT03104842) | Universitätsklinikum Hamburg-Eppendorf | 2017-08-15 |
| Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in Participants With Solid Tumors (NCT03313778) | ModernaTX, Inc. | 2017-08-14 |
| Accelerated Hypofractionated Radiotherapy in the Treatment of Malignant Pleural Mesothelioma (NCT03269227) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2017-08-14 |
| Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer (NCT02888743) | National Cancer Institute (NCI) | 2017-08-14 |
| Atezolizumab, Cobimetinib, and Eribulin in Treating Patients With Chemotherapy Resistant Metastatic Inflammatory Breast Cancer (NCT03202316) | M.D. Anderson Cancer Center | 2017-08-11 |
| Rate of Progression in USH2A-related Retinal Degeneration (NCT03146078) | Jaeb Center for Health Research | 2017-08-11 |
| Testing Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced Prostate Cancer (NCT02893917) | National Cancer Institute (NCI) | 2017-08-11 |
| A Study to Compare the Long-term Outcomes After Two Different Anaesthetics (NCT03089905) | Murdoch Childrens Research Institute | 2017-08-10 |
| Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention (NCT02295059) | City of Hope Medical Center | 2017-08-09 |
| Next Generation Pathogen Sequencing for Prediction of Adverse Events (NCT03226158) | St. Jude Children's Research Hospital | 2017-08-09 |
| Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant (NCT03192397) | Roswell Park Cancer Institute | 2017-08-09 |
| Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS) (NCT03114527) | Fox Chase Cancer Center | 2017-08-08 |
| Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (NCT03007147) | Children's Oncology Group | 2017-08-08 |
| Transcatheter Aortic Valve Replacement Versu Surgical Aortix Valve Replacement for Treating Elderly Patients With Severe Aortic Stenosis and Small Aortic Annuli: A Prospective Randomized Study The VIVA Trial (NCT03383445) | Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec | 2017-08-08 |
| Mind-Body Intervention in Glioma Couples (NCT03244995) | M.D. Anderson Cancer Center | 2017-08-06 |
| Pilot Study of T-APCs Following CAR T Cell Immunotherapy for CD19+ Leukemia (NCT03186118) | Seattle Children's Hospital | 2017-08-04 |
| Selumetinib and Olaparib in Solid Tumors (NCT03162627) | M.D. Anderson Cancer Center | 2017-08-04 |
| Pembrolizumab (Immunotherapy Drug) in Combination With Guadecitabine and Mocetinostat (Epigenetic Drugs) for Patients With Advanced Lung Cancer. (NCT03220477) | Memorial Sloan Kettering Cancer Center | 2017-08-04 |
| Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents (NCT03206671) | University Hospital Muenster | 2017-08-03 |
| 18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer (NCT03181867) | National Cancer Institute (NCI) | 2017-08-03 |
| Efficacy and Safety of Vedolizumab IV in Chinese Participants With Ulcerative Colitis (NCT03221036) | Takeda | 2017-08-03 |
| Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGA3 Achromatopsia (A Clarity Clinical Trial) (NCT02935517) | Beacon Therapeutics | 2017-08-03 |
| Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer (NCT02883062) | National Cancer Institute (NCI) | 2017-08-02 |
| A Study of AT132 in Young Children With X-Linked Myotubular Myopathy (XLMTM) (NCT03199469) | Astellas Gene Therapies | 2017-08-02 |
| Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies (NCT03217747) | M.D. Anderson Cancer Center | 2017-08-02 |
| Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma (NCT02704858) | Neonc Technologies, Inc. | 2017-08-01 |
| Evaluation of Proton Therapy in Pediatric Cancer Patients (NCT03223766) | St. Jude Children's Research Hospital | 2017-08-01 |
| Aging and Mixed Perturbation Training to Reduce Falls in Locomotion (NCT03199729) | University of Illinois at Chicago | 2017-08-01 |
| Danish Cardiovascular Screening Trial II (NCT03946410) | Odense University Hospital | 2017-08-01 |
| Sentinel Lymph Node Detection in Gastric Cancer Using a Dual Tracer (Superparamagnetic Iron Oxide and Methylene Blue): A Prospective Study With Histological and OSNA Validation (NCT07147452) | Hospital del SAS de Jerez | 2017-08-01 |
| An Asthma Collaboration to Reduce Childhood Asthma Disparities on the Navajo Nation (NCT03377647) | National Jewish Health | 2017-08-01 |
| Connective Tissue Graft Versus a Porcine-derived Membrane (Mucoderm) After Immediate Placement (NCT04737525) | Vilniaus Implantologijos Centro (VIC) Klinika | 2017-08-01 |
| Kinematic Versus Mechanical Alignment in Total Knee Replacement (NCT04384913) | Hannover Medical School | 2017-08-01 |
| Mechanisms of Cardiac Dysfunction in HIV and the Effect of Statins: a Cardiac MRI Study (NCT03238755) | Massachusetts General Hospital | 2017-07-31 |
| Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) (NCT03155620) | National Cancer Institute (NCI) | 2017-07-31 |
| Sorafenib, Busulfan and Fludarabine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant (NCT03247088) | M.D. Anderson Cancer Center | 2017-07-30 |
| JOURNEY II XR Safety and Effectiveness PMCF (NCT03136887) | Smith & Nephew, Inc. | 2017-07-28 |
| Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer (NCT03181100) | M.D. Anderson Cancer Center | 2017-07-27 |
| Study of E7386 in Participants With Selected Advanced Neoplasms (NCT03264664) | Eisai Inc. | 2017-07-27 |
| Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom (NCT02952508) | Cellectar Biosciences, Inc. | 2017-07-26 |
| The Chocolate Touch Study (NCT02924857) | TriReme Medical, LLC | 2017-07-26 |
| Asthma Research in Children and Adolescents (NCT04480242) | Parc de Salut Mar | 2017-07-26 |
| DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma (NCT03115333) | ECOG-ACRIN Cancer Research Group | 2017-07-25 |
| Palbociclib and Sorafenib, Decitabine, or Dexamethasone in Treating Patients With Recurrent or Refractory Leukemia (NCT03132454) | M.D. Anderson Cancer Center | 2017-07-25 |
| Savolitinib vs. Sunitinib in MET-driven PRCC. (NCT03091192) | AstraZeneca | 2017-07-25 |
| A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease (NCT03251118) | Target PharmaSolutions, Inc. | 2017-07-24 |
| Singapore Cohort of Patients with Advanced Heart Failure (NCT03089034) | Duke-NUS Graduate Medical School | 2017-07-24 |
| A Study of Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (NCT03141177) | Bristol-Myers Squibb | 2017-07-23 |
| Early Valve Replacement Guided by Biomarkers of LV Decompensation in Asymptomatic Patients With Severe AS (NCT03094143) | University of Edinburgh | 2017-07-21 |
| Understanding and Predicting Breast Cancer Events After Treatment (NCT02791581) | Wake Forest University Health Sciences | 2017-07-21 |
| Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer (NCT03092856) | University of Southern California | 2017-07-19 |
| Study to Determine if Patients Exposed to General Anesthesia Significant Numbers of Times Would Increase the Risk for Intraoperative Awareness. (NCT05857618) | University of Chicago | 2017-07-19 |
| Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases (NCT03223922) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-07-19 |
| A Randomized Trial of Pembrolizumab & Radiotherapy Versus Radiotherapy in High-Risk Soft Tissue Sarcoma of the Extremity (NCT03092323) | Sarcoma Alliance for Research through Collaboration | 2017-07-19 |